A total of 150 samples of pig tonsils were collected from slaughterhouse in Abidjan; the pigs were from pig farms located in different areas of Côte d'Ivoire. Samples were examined for the presence of Yersinia intermedia. Optimal recovery of Y. intermedia was achieved using two step enrichment procedures based on pre-enrichment in trypticase soya broth at 28 °C for 24 h, followed by cold enrichment method at 4 °C for 21 days in phosphate buffered saline broth. Then, Aulisio's alkali treatment method was performed before streaking onto MacConkey agar. Six strains of Yersinia intermedia were isolated and tested for the following characteristics associated to the virulence in Y. enterocolitica such as pyrazinamidase activity and autoagglutinability. All the six strains were all positive for the pyrazinamidase test and four of them were autoagglutinable. Four strains were biotype 4/autoagglutinable and two were biotype 5/O:7, 8-8-8,19. All the six strains of Yersinia intermedia were rhamnose negative and not motile at 25 °C. The results of antimicrobial resistance showed that all the strains presented multiple antibiotic resistance. The results indicate that 4% of pig tonsils from different farms collected at the slaughterhouse were contaminated with Yersinia intermedia. This study is the first which shows the presence of Yersinia intermedia in pigs in Côte d'Ivoire.
INTRODUCTION
The name Yersinia intermedia was suggested because this species has its biochemical and genetic properties intermediate to those of Yersinia enterocolitica, Y. pseudotuberculosis and Y. pestis. The species Yersinia intermedia is a member of the genus Yersinia which belongs to the Enterobacteriaceae family. Y. intermedia was separated from Yersinia enterocolitica and was defined biochemically and genetically as a new species in 1980. Acid production from alpha-Methyl-D-glucoside, D-melibiose, D-raffinose and L-rhamnose and utilization of Simmons citrate help distinguish it from Y. enterocolitica and other Yersinia species (Brenner et al., 1980) . Bacteria belonging to this species have been isolated from the environment (freshwater, sewage), various animals (fish, oysters, shrimp, snails, wild and domestic animals), food (milk, cream, meat) , and sometimes, healthy and sick humans, mainly from their stools (Martin et al., 2009) .
Y. intermedia apparently are not intestinal pathogens, but have been associated with wound and skin infections (Bottone, 1977; Hawkins and Brenner, 1978; Brenner, 1979) . Yersinia intermedia is usually considered non pathogenic for humans. Therefore, the pathogenic potential of Y. intermedia for humans has not been defined (Punsalung et al., 1987) .
Besides Y. enterocolitica, two other Yersinia species, Y. pseudotuberculosis and Y. pestis, have long been known to cause human disease (Carniel and Mollaret, 1990; Bottone, 1999) . The remaining seven species (Y. intermedia, Y. frederiksenii, Y. kristensenii, Y. aldovae, Y. rohdei, Y. bercovieri and Y. mollaretii) have generally been termed as "Y. enterocolitica-like". They have not been studied extensively, and because of the absence of classical Yersinia virulence markers, they have been generally considered to be environmental and nonpathogenic species. However, an increasing number of these non pathogenic species have been isolated from sick humans, raising the question of their possible pathogenicity (Sulakvelidze, 2000) .
The objectives of this work were to study Y. intermedia strains isolated from pig tonsils in Côte d'Ivoire and to determine their phenotype, biotype, serotype and evaluate their antibiotic resistance profile.
MATERIALS AND METHODS Sampling
From January 2009 to September 2010, a total of 150 samples of pig tonsils were collected from apparently healthy pigs at the pig slaughterhouse from Abidjan in Côte d'Ivoire. The tonsil samples were cut out immediately after evisceration and collected in sterile plastic bags. The samples were stored in an ice box at 4 °C within 2 hours during transportation from the site of collection and taken to the laboratory for immediate processing.
Isolation and identification of Yersinia intermedia
The samples were analyzed at the Laboratory of Biotechnology of the Department of Biosciences, University of Cocody. Tonsil samples were aseptically cut into pieces, 10 g per tonsil sample were inoculated into 90 ml of trypticase soya broth with novobiocin (mTSB-MERCK, Darmstadt, Germany) overnight at 28 °C. Then, 0.5 ml of TSB broth culture was transferred into 4.5 ml of PSMB (Phosphate buffered saline supplemented with 1% mannitol, 1% sorbitol and 0.15% bile salts), which was incubated at 4 °C for 21 days. Aulisio's alkali treatment method (Aulisio et al., 1980) 
Biochemical properties
These biochemical tests were performed at the French Yersinia reference laboratory ('Centre National des Yersinia, Institut Pasteur', Paris, France). Biochemical tests were performed with API 20E and API 50CH strips (BioMérieux, Marcy l'EtoileFrance). In addition, biochemical tests based on acid production from L-rhamnose, Dmelibiose, D-raffinose and -Methyl-Dglucoside and the utilization of Simmons citrate were done according to the biotyping scheme of Brenner (Brenner et al., 1980) .
Serotyping
This was performed at Pasteur Institut, Yersinia Research Unit, Yersinia National Reference Laboratory, Paris, France. All the strains were serotyped with 53 specific antisera. O antigens were detected by slide agglutination with the 53 difference antisera, according to the typing scheme of Wauters et al. (Wauters et al., 1972; Wauters et al., 1991) .
Phenotypic virulence markers Pyrazinamidase
The pyrazinamidase activity was tested as described Kandolo and Wauters (1985) . Strains were inoculated over the entire slant of pyrazinamidase agar, inoculated at 28 °C for 48 h, and tested with 1 ml of fresh prepared 1% solution of ferrous ammonium sulfate (aqueous). A positive pyrazinamidase reaction was indicated by a pink to brown color that developed on the slant.
Autoagglutination
The strains were examined for their ability to autoagglutinated at 37 °C in trypticase soya broth (Biokar Diagnostics, Beauvais, France) as suggested by Kandolo and Wauters (1985) . Strains were positive if autoagglutination occurred when strains grown at 37 °C.
Antibiotic susceptibilities testing
Antibiotic susceptibilities were determined by the disc diffusion method on Mueller-Hinton agar (Oxoid, France), and the results were interpreted according to the criteria of the 'Comité de l'Antibiogramme' of the French Society for Microbiology. The plates were incubated (24-48 h at 37 °C) and resistance was scared via visual examination. The antimicrobial drugs tested and their concentrations on the discs (Bio-Rad, MarnesLa-Coquette, France) were as following: Ampicillin (10 µg), ciprofloxacin (5 µg), kanamycin (30 µg), amikacin (30 µg), chloramphenicol (30 µg), penicillin (10 UI), trimethoprim/sulfamethoxazole (1.25/23.75 µg), imipenem (10 µg), amoxicillin (25 µg), ceftriaxone (30 µg), ceftazidime (30 µg) , amoxicillin/clavulanic acid (20 µg/10 µg), cephalotin (30 µg), tetracycline (30 UI), cefoxitin (30 µg) and ticarcillin (75 µg).
RESULTS

Sampling and isolation
From 150 pig tonsil samples, 6 (4%) Yersinia intermedia strains were isolated.
Biochemical properties
All Punsalang et al. (1987) isolated 6 Y. intermedia from 860 stool cultures (0.7%). However, our studies generated higher isolation (4%) than the results in these studies. Some researchers reported that even higher isolation rate were detected compared to the results of this study. For instance, Nesbakken et al. (1985) in Norway and Franzin et al. (1984) in Italy found that Y. intermedia were recovered from 7.9% of retail pork products and 23.3% from raw milk. The differences between the findings of various authors and those of this study might be due to several factor such as isolation methods, number of analyzed samples, season, and geographical location. These factors may cause an increase or decrease in the prevalence of the Yersinia spp. as Siriken (2004) revealed. In addition, the present study was performed in Abidjan, where the climate is generally warm. Also, it is known that the isolation ratio of Y. intermedia is higher in cold climate. The best results of isolation were obtained by combining pre-enrichment in Trypticase Soya broth with novobiocin overnight at 28 °C, cold enrichment method in PSMB broth for 3 weeks at 4 °C, Aulisio's alkali treatment method and SMAC agar, as previously reported by others (Mehlman et al., 1978; Doyle and Hugdahl, 1983; Martinez, 2010) . It appeared that some enrichment procedures were better than others. For example, Jiang et al. (2000) reported that the highest isolation rate was 32% for the 4 °C/3-week enrichment, followed by 28% for the 4 °C/2-week enrichment, 26% for the 25 °C/24-h enrichment, 22% for the 4 °C/1-week enrichment, and 10% for direct plating.
Therefore, the isolation ratio may depend on the procedure. Furthermore, the identification of Y. enterocolitica sensu stricto as Y. intermedia by traditional agar plate techniques (ISO standard 10273:2003) is complicated by the fact that on the commonly used selective agar plates, especially the cefsulodin-irgasannovobiocin (CIN) agar, several unrelated bacteria also grow (Arnold et al., 2004; Neubauer et al., 2001 ). In addition, some Yersinia strains are inhibited by CIN agar (Fukushima and Gomyoda, 1986) .
In our study, we found that phenotypic identification of Yersinia intermedia was problematic. All the six strains studied here were initially identified as Yersinia enterocolitica by an API 20E commercial identification kit and finally identified as Y. intermedia by Yersinia National Reference Laboratory at Pasteur institute. Likewise, the six strains of Punsalang et al. (1987) were all misidentified as Yersinia enterocolitica by the API 20E system and finally identified as Y. intermedia. In fact, Y. intermedia was proposed by Brenner and his colleagues (Brenner et al., 1980) for Yersinia enterocolica-like bacteria which are rhamnose, melibiose, raffinose and alphaMethyl-D-glucoside positive strains. After biochemical and DNA hybridization studies, these workers subdivided Y. intermedia into eight biogroups. Therefore, according to this scheme, which is based on the acidification of L-rhamnose, D-melibiose, D-raffinose andMethyl-D-glucoside and Simmons citrate utilization, the six Y. intermedia strains which were obtained from pig tonsils in this study belong to two biotypes (biotype 4 and 5). Biotype 4 was found to be predominant among the isolates. All the Y. intermedia strains were rhamnose negative and these constitute a rare biotype. Also, all the isolates were non motile at 25 °C and 37 °C. Unlike, most strains isolated in Europe and America were motile at 25 °C (Brenner et al., 1980) . The 6 isolates fit into two biotypes and two serotypes, four were biotype 4/autoagglutinable and two strains of biotype 5/O:7,8-8-8,19 . In a previous study, Singh and Virdi (1999) reported the isolation of Y. intermedia biotype 5/O:7,8-8-8,19 in pork from India. None of Y. intermedia strains examined by Kay et al. (1983) , Prpic et al. (1985) and Punsalang et al. (1987) were autoagglutinable. In contrast to these findings, our study reported that four of our six strains were autoagglutinable. Likewise, Agbonlahor (1986) reported that four of five Y. intermedia isolated from patient with diarrhea in Nigeria were autoagglutinable. Kandolo and Wauters (1985) :7,8-8-8,19 didn't possess the virulence genes usually found in pathogenic Yersinia species (lack of pyrazinamidase activity). For the present, our Y. intermedia isolates should be considered as nonpathogenic strains or environment species. Although, the strains were usually considered to be non pathogenic for humans, it has been suggested that they may become host-adapted for humans as opportunistic pathogens and be clinically significant in the future (Brenner et al., 1980; Kay et al. 1983 (Johnson, 1998) .
Our results generally agree with those of others with regard in vitro to susceptibilities of ciprofloxacin, kanamycin, amikacin, chloramphenicol, trimethoprim/ sulfamethoxazole, imipenem, ceftriaxone, ceftazidime and tetracycline (Franzin et al., 1984; Ahmedy et al., 1985) . The results of antimicrobial resistance showed that the strains of Y. intermedia presented multiple antibiotic resistances as seen with ampicillin, amoxicillin, amoxicillin/clavulanic acid, cephalotin, penicillin and ticarcillin. The resistance profile of the strains analyzed here was similar to those of others studies (Franzin et al., 1984; Tzelepi et al., 1999; Stock and Wiedemann, 2003) . Resistance to ampicillin and numerous cephalosporins (cephalotin) was common to the strains of Y. enterocolitica (Falao et al., 2004) . These and related drugs are used in veterinary medicine to treat swine (Prescott and Baggot, 1988) . Therefore, the administration of antimicrobial agents for the treatment of bacterial infections in both veterinary and human medicine poses a potential risk because it leads to the selection of strains resistant to antibiotics. A high incidence of resistant bacteria has particularly been reported from developing countries, where antibiotics are freely available and their use is not subjected to any regulation (Levy, 1998) . The main reason for the increase in resistant bacteria population is apparently in the application of antibiotics as prophylactics and growth stimulants in animals (Aarestrup, 1999; Teuber, 2001) .
The results of our study showed that 4% of pig tonsils from different pig farms tested at slaughterhouse were contaminated with Y. intermedia. The present study supports that swine represent a potential reservoir of Yersinia intermedia strains which are possibly pathogenic for humans. To our knowledge, no report of Y. intermedia isolation from Côte d'Ivoire was made before. So, this study is the first which showed the existence of Yersinia intermedia in our country.
